These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13125178)

  • 1. [Studies on glaucoma. III. Glaucoma and the vegetative nervous system; glaucoma and endocrine secretions; glaucoma, allergy and stress; glaucoma and its therapy; conclusions].
    ROSSETTI D
    Ann Ottalmol Clin Ocul; 1953 Nov; 79(11):591-624. PubMed ID: 13125178
    [No Abstract]   [Full Text] [Related]  

  • 2. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
    Osborne SA; Montgomery DM; Morris D; McKay IC
    Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation of retinal ganglion cell fate in glaucoma.
    Wax MB; Tezel G
    Exp Eye Res; 2009 Apr; 88(4):825-30. PubMed ID: 19233171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effect profile of brimonidine tartrate in children.
    Al-Shahwan S; Al-Torbak AA; Turkmani S; Al-Omran M; Al-Jadaan I; Edward DP
    Ophthalmology; 2005 Dec; 112(12):2143. PubMed ID: 16225927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction.
    Seider N; Miller B; Beiran I
    Am J Ophthalmol; 2008 Jan; 145(1):120-123. PubMed ID: 17915187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Condition of the vegetative nervous system in glaucoma].
    ENIKEEVA KH; KHASANOVA NK; RAKHIMZHANOVA MT
    Vestn Oftalmol; 1952; 31(5):24-9. PubMed ID: 13005911
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population.
    Bhosle MJ; Reardon G; Camacho FT; Anderson RT; Balkrishnan R
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):100-11. PubMed ID: 17719512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and nitrative stress markers in glaucoma.
    Aslan M; Cort A; Yucel I
    Free Radic Biol Med; 2008 Aug; 45(4):367-76. PubMed ID: 18489911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma.
    Pache M; Flammer J
    Surv Ophthalmol; 2006; 51(3):179-212. PubMed ID: 16644363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escalation of glaucoma therapy after penetrating keratoplasty.
    Al-Mohaimeed M; Al-Shahwan S; Al-Torbak A; Wagoner MD
    Ophthalmology; 2007 Dec; 114(12):2281-6. PubMed ID: 18054642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRT III glaucoma probability score and Moorfields regression across the glaucoma spectrum.
    Reddy S; Xing D; Arthur SN; Harizman N; Dorairaj S; Ritch R; Liebmann JM
    J Glaucoma; 2009; 18(5):368-72. PubMed ID: 19525726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.
    Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U
    Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma probability score vs Moorfields classification in normal, ocular hypertensive, and glaucomatous eyes.
    Moreno-Montañés J; Antón A; García N; Mendiluce L; Ayala E; Sebastián A
    Am J Ophthalmol; 2008 Feb; 145(2):360-368. PubMed ID: 18045569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center.
    Heinz C; Koch JM; Zurek-Imhoff B; Heiligenhaus A
    Ocul Immunol Inflamm; 2009; 17(4):243-8. PubMed ID: 19657977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of indices of the functional state of the nervous system in glaucoma].
    KUNICHEVA GS
    Vestn Oftalmol; 1958; 71(5):3-18. PubMed ID: 13603966
    [No Abstract]   [Full Text] [Related]  

  • 16. Complementary therapy for the treatment of glaucoma: a perspective.
    Ritch R
    Ophthalmol Clin North Am; 2005 Dec; 18(4):597-609. PubMed ID: 16314222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the functional state of the central nervous system in the initial stage of glaucoma].
    IGOSHINA NF
    Vestn Oftalmol; 1957; 70(6):11-7. PubMed ID: 13530567
    [No Abstract]   [Full Text] [Related]  

  • 18. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM; Freedman SF
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin histamine reaction as index of the functional condition of the nervous system of glaucoma patients].
    BAKURSKAIA VIa
    Vestn Oftalmol; 1959; 72(3):51-6. PubMed ID: 13659809
    [No Abstract]   [Full Text] [Related]  

  • 20. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma.
    Gherghel D; Hosking SL; Orgül S
    Surv Ophthalmol; 2004; 49(5):491-508. PubMed ID: 15325194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.